C5A RECEPTOR MODULATORS

The present invention relates to derivatives of formula (I) Formula (I) wherein Ring A, W, X, Y, Z, R1, R2, R3 and R4 are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containin...

Full description

Saved in:
Bibliographic Details
Main Authors RENNEBERG DORTE, MURPHY MARK, HUBLER FRANCIS, FROIDEVAUX SYLVIE, STAMM SIMON
Format Patent
LanguageChinese
English
Published 18.09.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to derivatives of formula (I) Formula (I) wherein Ring A, W, X, Y, Z, R1, R2, R3 and R4 are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as C5a receptor modulators. 本发明涉及式(I)的衍生物,式(I)其中环A、W、X、Y、Z、R、R、R和R如说明书中所述,其制备,其药学上可接受的盐,以及其作为药物的用途,包含一种或多种式(I)化合物的药物组合物,以及尤其是用作C5a受体调节剂的用途。
Bibliography:Application Number: CN201980009036